CIK 0001815442
- Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812992166
- Phone
- +1 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-01 | Booth Bruce Director | Sale | −15,804 | $30.57 | $483K | 1,050,584 |
| 2022-11-01 | Booth Bruce Director | Sale | −3,727 | $31.08 | $116K | 5,537,456 |
| 2022-11-01 | Booth Bruce Director | Sale | −1,044 | $31.08 | $32K | 1,049,540 |
| 2022-11-01 | Atlas Venture Fund X, L.P. 10% owner | Sale | −56,455 | $30.57 | $1.7M | 5,541,183 |
| 2022-11-01 | Atlas Venture Fund X, L.P. 10% owner | Sale | −15,804 | $30.57 | $483K | 1,050,584 |
| 2022-11-01 | Atlas Venture Fund X, L.P. 10% owner | Sale | −3,727 | $31.08 | $116K | 5,537,456 |
| 2022-11-01 | Atlas Venture Fund X, L.P. 10% owner | Sale | −1,044 | $31.08 | $32K | 1,049,540 |
| 2022-10-31 | Booth Bruce Director | Sale | −94,239 | $30.23 | $2.8M | 5,597,638 |
| 2022-10-31 | Booth Bruce Director | Sale | −26,383 | $30.23 | $798K | 1,066,388 |
| 2022-10-31 | Atlas Venture Fund X, L.P. 10% owner | Sale | −94,239 | $30.23 | $2.8M | 5,597,638 |
| 2022-10-31 | Atlas Venture Fund X, L.P. 10% owner | Sale | −26,383 | $30.23 | $798K | 1,066,388 |
| 2022-10-28 | Booth Bruce Director | Sale | −71,135 | $30.00 | $2.1M | 5,691,877 |
| 2022-10-28 | Booth Bruce Director | Sale | −19,915 | $30.00 | $597K | 1,092,771 |
| 2022-10-28 | Atlas Venture Fund X, L.P. 10% owner | Sale | −71,135 | $30.00 | $2.1M | 5,691,877 |
| 2022-10-28 | Atlas Venture Fund X, L.P. 10% owner | Sale | −19,915 | $30.00 | $597K | 1,092,771 |
| 2022-10-21 | Jacobs Bruce N. Chief Financial Officer | Exercise or conversion | +10,000 | $2.08 | $21K | 81,279 |
| 2022-10-21 | Jacobs Bruce N. Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 139,899 | ||
| 2022-10-17 | Jacobs Bruce N. Chief Financial Officer | Exercise or conversion | +10,000 | $2.08 | $21K | 71,279 |
| 2022-10-17 | Jacobs Bruce N. Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 149,899 | ||
| 2022-10-17 | Mainolfi Nello Chief Executive Officer | Exercise or conversion | +32,056 | $2.08 | $67K | 534,255 |
Page 36 of 41 · 810 trades